The two plaintiffs in the first Xarelto trials are seeking new trials after both ended in defense verdicts, as a third bellwether trial is slated to begin early next month over claims the manufacturers failed to provide adequate warning of the risk of bleeding injuries.…
The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety. PRADAXA LAWSUIT STATUS: In May 2014, Boehringer Ingelheim and attorneys for plaintiffs reached a Pradaxa settlement agreement for $650 million, which would resolve about 4,000 Pradaxa bleeding lawsuits.…
The blood thinner Xarelto is linked to severe and potentially deadly bleeding events. Product liability lawyers are investigating potential Xarelto lawsuits.…
The makers of Xarelto are trying to have a lower dose version approved to fight blood clots even as they face thousands of product liability lawsuits over bleeding injuries.…
A small Eliquis recall has been announced after a customer found pills of the wrong dosage in a bottle of the blood thinning drug.…
A Xarelto lawsuit filed over bleeding injuries indicates that manufacturers knew the drug would cause health risks before putting it on the market.…
The U.S. District Judge recently assigned to preside over all federal Eliquis injury lawsuits has granted a motion to dismiss filed by the drug makers, which may impact dozens of other claims brought on behalf of individuals nationwide who experienced uncontrollable bleeding problems.…
The first Xarelto bellwether trial has ended in a defense verdict after the jury determined that the manufacturers had not failed to adequately warn about the risk of bleeding injuries.…
Trial is underway in the first out of more than 16,000 Xarelto lawsuits pending throughout the federal court system, each involving similar allegations that the drug caused users to suffer severe and uncontrollable bleeding problems.…
A federal judge has denied partial summary judgments for two pending Xarelto bellwether cases, allowing the lawsuits to move forward to trial in the next few weeks.…
